Document ID: chunk:federal_register_of_legislation:F2021L00216:reg:9
Version: federal_register_of_legislation:F2021L00216
Segment Type: reg
Provision Reference: reg 9
Character Range: 3864–5400

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, acute lymphoblastic leukaemia/lymphoblastic lymphoma or death from acute lymphoblastic leukaemia/lymphoblastic lymphoma is connected with the circumstances of a person's relevant service:
(1)          having received a cumulative equivalent dose of at least 0.05 sievert of ionising radiation to the bone marrow at least two years before the clinical onset of acute lymphoblastic leukaemia/lymphoblastic lymphoma;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(2)          taking an alkylating agent or a DNA topoisomerase II inhibitor for the treatment of a malignant neoplasm before the clinical onset of acute lymphoblastic leukaemia/lymphoblastic lymphoma, and:
(a)          the first exposure occurred at least one year before the clinical onset of acute lymphoblastic leukaemia/lymphoblastic lymphoma; and
(b)          if exposure ceased before the clinical onset of acute lymphoblastic leukaemia/lymphoblastic lymphoma, then that onset occurred within 20 years of cessation;
(3)          undergoing organ or tissue transplantation, excluding corneal transplant, before the clinical onset of acute lymphoblastic leukaemia/lymphoblastic lymphoma;
Note: organ or tissue transplantation is defined in the Schedule 1 - Dictionary.
(4)          inability to obtain appropriate clinical management for acute lymphoblastic leukaemia/lymphoblastic lymphoma.